Palumbo Wealth Management’s Organogenesis Holdings ORGO Stock Holding History

Palumbo Wealth Management’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$137K	Buy	57,849 +19,798	+52%	+$68.6K	0.03%	215
2025 Q4	$197K	Buy	+38,051	New	+$184K	0.05%	210
2025 Q3	–	Sell	-41,060	Closed	-$150K	–	213
2025 Q2	$150K	Buy	41,060 +2,394	+6%	+$8.92K	0.05%	190
2025 Q1	$167K	Buy	38,666 +18,476	+92%	+$74.6K	0.06%	172
2024 Q4	$64.6K	Buy	+20,190	New	+$67.7K	0.02%	171
2024 Q1	–	Sell	-11,132	Closed	-$45.5K	–	143
2023 Q4	$45.5K	Buy	+11,132	New	+$31.2K	0.02%	120

Other funds holding ORGO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Palumbo Wealth Management's ORGO Position: Q1 2026 in Review

Palumbo Wealth Management increased its Organogenesis Holdings (ORGO) stake by 52% in Q1 2026, buying an estimated $68.6K and bringing the position to 57,849 shares worth $137K. The position accounts for 0.03% of the portfolio, ranked #215.

Palumbo Wealth Management first reported a position in ORGO in Q4 2023 and has held it in 6 quarters since. The position peaked at $197K in Q4 2025. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

Palumbo Wealth Management held 57,849 shares of Organogenesis Holdings worth $137K as of Q1 2026.
Palumbo Wealth Management bought 19,798 Organogenesis Holdings shares in Q1 2026, an estimated $68.6K.
Organogenesis Holdings made up 0.03% of Palumbo Wealth Management's portfolio in Q1 2026, its #215 holding.
Palumbo Wealth Management first reported a position in Organogenesis Holdings in Q4 2023 and has held it in 6 quarters since.
Palumbo Wealth Management's Organogenesis Holdings position peaked at $197K in Q4 2025.
121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Palumbo Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.